[CAS NO. 6640-22-8]  Pamoic acid disodium

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [6640-22-8]

Catalog
HY-W010907
Brand
MCE
CAS
6640-22-8

DESCRIPTION [6640-22-8]

Overview

MDL-
Molecular Weight432.33
Molecular FormulaC23H14Na2O6
SMILESOC1=C(C(C=CC=C2)=C2C=C1C(O[Na])=O)CC(C(C=CC=C3)=C3C=C4C(O[Na])=O)=C4O

For research use only. We do not sell to patients.

Summary

Pamoic acid disodium is a potent GPR35 agonist with an EC 50 value of 79 nM. Pamoic acid disodium induces GPR35 internalization and activates ERK1/2 with EC 50 values of 22 nM and 65 nM, respectively. Pamoic acid disodium potently recruits β-arrestin2 to GPR35 and has an antinociceptive effect [1] .


IC50 & Target

EC50: 79 nM (GPR35), 65 nM (ERK1/2) [1]


In Vitro

Pamoic acid (0.1 nM-0.1 mM) induces GPR35a internalization with an EC 50 value of 22 nM [1] .
Pamoic acid (0-10 μM) induces ERK1/2 activation [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis [1]

Cell Line: U2OS cells
Concentration: 1, 10, 100 nM and 1, 10 μM
Incubation Time: 15 min
Result: A concentration-dependent activation of ERK1/2 was observed with an EC 50 of 65 nM.

In Vivo

Pamoic acid disodium (0-100 mg/kg; s.c.; once) induces a dose-related antinociception in the abdominal constriction test [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Swiss-Webster mice (30–35 g) [1]
Dosage: 25, 50, and 100 mg/kg
Administration: Subcutaneous injection, once
Result: Elicited dose-related antinociception, the dose causing 50% antinociception being 40.5 mg/kg.

Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

4°C, sealed storage, away from moisture

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)


Solvent & Solubility

In Vitro:

DMSO : 100 mg/mL ( 231.30 mM ; ultrasonic and warming and heat to 60°C)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.3130 mL 11.5652 mL 23.1305 mL
5 mM 0.4626 mL 2.3130 mL 4.6261 mL
10 mM 0.2313 mL 1.1565 mL 2.3130 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

    Solubility: ≥ 7.5 mg/mL (17.35 mM); Clear solution

  • 2.

    Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)

    Solubility: ≥ 7.5 mg/mL (17.35 mM); Clear solution

* All of the co-solvents are available by MCE.


Synonyms

2-Naphthalenecarboxylic acid, 4,4′-methylenebis[3-hydroxy-, sodium salt (1:2)
2-Naphthoic acid, 4,4′-methylenebis[3-hydroxy-, disodium salt
2-Naphthalenecarboxylic acid, 4,4′-methylenebis[3-hydroxy-, disodium salt
Disodium pamoate
Sodium pamoate
Disodium 1,1′-methylenebis(2-hydroxy-3-naphthoate)
Pamoic acid disodium salt
Disodium embonate